Indianapolis-based Eli Lilly announced Friday it will acquire California-based biopharmaceutical company Dermira for a little more than $1 billion.

After a report criticized Eli Lilly and Co. for not doing enough to make affordable insulin available, the company launched a campaign Thursday to raise awareness of their discount options.

The facility upgrades in automation and data analytics will be some of Lilly's most advanced manufacturing technologies, the company says.

Indianapolis-based Eli Lilly is challenging a new federal rule that would require drug companies to include prices in TV ads.

The Indianapolis drugmaker has begun selling its own generic version of Humalog U-100 under the chemical name insulin lispro. It will cost $137.35 per vial, or $265.20 for a package of five KwikPens.

Six Indiana organizations have pitched in to buy a new high-tech microscope. The nearly $9 million machine is a cryo-electron microscope that allows scientists to examine molecules at the atomic level.

On Tuesday, the company began running TV ads for a popular diabetes drug that don't give the price but direct viewers to the website .

Lilly shares have climbed 30 percent since the beginning of the year, while the Standard & Poor's 500 index has risen slightly more than 2 percent.

Contract negotiations with cleaning companies start in two weeks.

Drug maker Eli Lilly and Co. sought a 10-year tax abatement in exchange for the company investing $159 million to boost its insulin manufacturing operations at its Indianapolis technical center.